Tomás P. Carroll
- Cancer Research top 2%
- Protease and Inhibitor Mechanisms 31
- Hematology top 5%
- Blood Coagulation and Thrombosis Mechanisms 13
-
- Neonatal Respiratory Health Research 8
- Cystic Fibrosis Research Advances 7
- Pulmonary Hypertension Research and Treatments 7
- Immunology top 10%
- Oncology top 5%
- Peptidase Inhibition and Analysis 23
-
- Endoplasmic Reticulum Stress and Disease 6
- Calpain Protease Function and Regulation 3
- Co-authors
- Noel G. McElvaneyShane O’NeillCatherine M. GreeneClifford C. TaggartJames DevaneyEmer P. ReevesOliver J. McElvaneyCatherine O’Connor
- Journals
- New England Journal of Medicine (1 paper)Journal of Biological Chemistry (2 papers)Journal of Clinical Investigation (1 paper)
- Partner nations
- IrelandUnited StatesCanada
In The Last Decade
Tomás P. Carroll
52 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 102
- Cancer Research 808
- Hematology 285
- Pulmonary and Respiratory Medicine 725
- Immunology 395
- Oncology 485
Countries citing papers authored by Tomás P. Carroll
This map shows the geographic impact of Tomás P. Carroll's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomás P. Carroll with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomás P. Carroll more than expected).
Fields of papers citing papers by Tomás P. Carroll
This network shows the impact of papers produced by Tomás P. Carroll. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomás P. Carroll. The network helps show where Tomás P. Carroll may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Tomás P. Carroll, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2024 | 2 | |
| 3 | 2023 | 5 | |
| 4 | 2023 | 0 | |
| 5 | 2023 | 0 | |
| 6 | 2023 | 3 | |
| 7 | 2023 | 0 | |
| 8 | 2021 | 7 | |
| 9 | 2020 | 28 | |
| 10 | 2019 | 17 | |
| 11 | 2014 | 1 | |
| 12 | 2014 | 118 | |
| 13 | 2013 | 64 | |
| 14 | 2011 | 11 | |
| 15 | 2010 | 94 | |
| 16 | 2010 | 58 | |
| 17 | 2009 | 59 | |
| 18 | 2005 | 182 | |
| 19 | 2003 | 192 | |
| 20 | 1995 | 15 |
About Tomás P. Carroll
Tomás P. Carroll is a scholar working on Cancer Research, Hematology and Oncology, having authored 59 papers that have together received 2.0k indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (31 papers), Peptidase Inhibition and Analysis (23 papers), Blood Coagulation and Thrombosis Mechanisms (13 papers), Neonatal Respiratory Health Research (8 papers), Cystic Fibrosis Research Advances (7 papers), Pulmonary Hypertension Research and Treatments (7 papers), Endoplasmic Reticulum Stress and Disease (6 papers) and Calpain Protease Function and Regulation (3 papers). The work is most often cited by research in Cancer Research (808 citations), Hematology (285 citations) and Pulmonary and Respiratory Medicine (725 citations). Tomás P. Carroll has collaborated with scholars based in Ireland, United States and Canada. Frequent co-authors include Noel G. McElvaney, Shane O’Neill, Catherine M. Greene, Clifford C. Taggart, James Devaney, Emer P. Reeves, Oliver J. McElvaney, Catherine O’Connor, Alessandro N. Franciosi and Emer Kelly. Their work appears in journals such as New England Journal of Medicine, Journal of Biological Chemistry and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.